Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-09-26
2006-09-26
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C549S009000, C549S013000, C549S072000
Reexamination Certificate
active
07112683
ABSTRACT:
The present invention relates to cyclic sulfone moiety-containing hydroxyethylamine protease inhibitor compounds and pharmaceutical or method of use therefor, particularly as an inhibitor of HIV protease.
REFERENCES:
patent: 4450164 (1984-05-01), Bristol et al.
patent: 4477441 (1984-10-01), Boger et al.
patent: 4514391 (1985-04-01), Gordon et al.
patent: 4548926 (1985-10-01), Matsueda et al.
patent: 4599198 (1986-07-01), Hoover
patent: 4616088 (1986-10-01), Ryono et al.
patent: 4668769 (1987-05-01), Hoover
patent: 4668770 (1987-05-01), Boger et al.
patent: 4757050 (1988-07-01), Natarajan et al.
patent: 4857507 (1989-08-01), Rosenberg et al.
patent: 4880938 (1989-11-01), Freidinger
patent: H725 (1990-01-01), Gordon
patent: 4963530 (1990-10-01), Hemmi et al.
patent: 4977277 (1990-12-01), Rosenberg et al.
patent: 5484926 (1996-01-01), Dressman et al.
patent: 5514801 (1996-05-01), Bertenshaw et al.
patent: 5824688 (1998-10-01), Kalish et al.
patent: 5827858 (1998-10-01), Kalish et al.
patent: 5827859 (1998-10-01), Kalish et al.
patent: 5827891 (1998-10-01), Dressman et al.
patent: 5849784 (1998-12-01), Bertenshaw et al.
patent: 6265583 (2001-07-01), Bertenshaw et al.
patent: 6329524 (2001-12-01), Bertenshaw et al.
patent: 6552203 (2003-04-01), Bertenshaw et al.
patent: 6875790 (2005-04-01), Bertenshaw et al.
patent: 79823/87 (1988-04-01), None
patent: 0104041 (1984-03-01), None
patent: 0114993 (1984-08-01), None
patent: 172347 (1986-02-01), None
patent: 223437 (1987-05-01), None
patent: 0264795 (1988-04-01), None
patent: 337714 (1989-10-01), None
patent: 0342541 (1989-11-01), None
patent: 0346847 (1989-12-01), None
patent: 356223 (1990-02-01), None
patent: 289898 (1990-10-01), None
patent: 389898 (1990-10-01), None
patent: 393445 (1990-10-01), None
patent: 393457 (1990-10-01), None
patent: 402646 (1990-12-01), None
patent: 2184730 (1987-07-01), None
patent: 2200115 (1988-07-01), None
patent: 2209752 (1989-05-01), None
patent: WO 84/03044 (1984-08-01), None
patent: WO 92/00750 (1992-01-01), None
Roberts et al., “Rational Design of Peptide-Based Proteinase Inhibitors”,Science,248, 358 (1990.
Erickson et al., “Design Activity and 2.8A Crystal Structure of C2Symmetric Inhibitor Complexed to HIV-1 Protease”,Science,249, 527 (1990).
Pearl et al., “Sequence specificity of Retroviral Protease”,Nature,vol. 328, No. 6130, Aug. 6-12, 1987, p. 482.
Martin, Drugs of the Future, 1991 16(3), 210-212.
Meek et al., “Inhibition of HIV-1 Protease in Infected T-lymphocytes by Synthetic Peptide Analogues”,Nature,343, 90 (1990.
McQuade et al., “A Synthetic HIV-1 Protease Inhibitor with Antiviral Activity Arrests HIV-Like Particle Maturation”,Science,274, 454-456 (1990).
D.H. Rich and V.J. Hunby: Dept. Struct. Funct. Proc. Am. Peptide Inhibitors of Protease Sym. 8thed., pp. 511-520 (1983).
Rosenberg et al.,J. Med. Chem.,30, 1224-1228 (1987).
U.S. Appl. No. 07/789,646 by John T. Talley et al., filed Nov. 14, 1991, entitled “Retroviral Protease Inhibitors” (07-21(807)A).
U.S. Appl. No. 07/789,645 by John T. Talley et al., filed Nov. 14, 1991, entitled “Retroviral Protease Inhibitors” (07-21(829)A).
U.S. Appl. No. 07/789,644 by John T. Talley et al., filed Nov. 14, 1991, entitled “Retroviral Protease Inhibitors” (07-21(831)A).
U.S. Appl. No. 07/789,642 by John T. Talley et al., filed Nov. 14, 1991, entitled “Retroviral Protease Inhibitors” (07-21(827)A).
U.S. Appl. No. 07/789,643 by John T. Talley et al., filed Nov. 14, 1991, entitled “Retroviral Protease Inhibitors” (07-21(830)A).
U.S. Appl. No. 07/886,556 by John T. Talley et al., filed May 20, 1992, entitled “Retroviral Protease Inhibitors” (2-2709/1).
U.S. Appl. No. 07/886,663 by John T. Talley et al., filed May 20, 1992, entitled “Retroviral Protease Inhibitors” (2-2710/1).
U.S. Appl. No. 07/886,531 by John T. Talley et al., filed May 20, 1992, entitled “Retroviral Protease Inhibitors” (2-2711/1).
U.S. Appl. No. 07/886,547 by John T. Talley et al., filed May 20, 1992, entitled “Retroviral Protease Inhibitors” (2-2712/1).
U.S. Appl. No. 07/886,700 by John T. Talley et al., filed May 20, 1992, entitled “Retroviral Protease Inhibitors” (07-21(879A).
U.S. Appl. No. 07/935,071 by Michael Vazquez et al., filed Aug. 25, 1992, entitled Sulfonylakanoylamino Hydroxyethylamino Sulfonamides Useful as Retroviral Protease Inhibitors (C-2703).
U.S. Appl. No. 07/935,490 by Michael Vazquez et al., filed Aug. 25, 1992, entitled Succinoylamino Hydroxyethylamino Sulfonamides Useful as Retroviral Protease Inhibitors (C-2704).
U.S. Appl. No. 07/934,984 by Michael Vazquez et al., filed Aug. 25, 1992, entitled α- and β-amino Acid Hydroxyethylamino Sulfonamides Useful as Retroviral Protease Inhibitors (C-2705).
U.S. Appl. No. 07/969,683 by Michael Vazquez et al., filed Oct. 30, 1992, entitled Succinolyamino Hydroxyethylamino Sulfamic Acids Useful as Retroviral Protease Inhibitors (C-2741).
U.S. Appl. No. 07/969,612 by Michael Vazquez et al., filed Oct. 30, 1992, entitled Sulfonylakanoylamino Hydroxyethylamino Sulfamic Acids Useful as Retroviral Protease Inhibitors (C-2742).
U.S. Appl. No. 07/968,712 by Michael Vazquez et al., filed Oct. 30, 1992, entitled α- β-Amino Acid Hydroxyethylamino Sulfony Urea Derivatives Useful as Retroviral Protease Inhibitors (C-2751).
U.S. Appl. No. 07/969,616 by Michael Vazquez et al., filed Oct. 30, 1992, entitled Sulfonylalkanoylamino Hydroxyethylamino Sulfonyl Urea Derivatives Useful as Retroviral Protease Inhibitors (C-2752).
U.S. Appl. No. 07/969,682 by Michael Vazquez et al., filed Oct. 30, 1992, entitled Succinolymamino Hydroxyethylamino Sulfonyl Urea Derivatives Useful as Retroviral Protease Inhibitors (C-2753).
U.S. Appl. No. 07/968,730 by Michael Vazquez et al., filed Oct. 30, 1992, entitled α- β-Amino Acid Hydroxyethylamino Sulfamic Acid Derivatives Useful as Retroviral Protease Inhibitors (C-2740).
Bertenshaw Deborah E.
Chrusciel Robert A.
Clare Michael
Getman Daniel P.
Heintz Robert M.
Banner & Witcoff , Ltd.
G.D. Searle & Co.
Monsanto Company
Seaman D. Margaret
LandOfFree
Cyclic sulfone containing retroviral protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic sulfone containing retroviral protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic sulfone containing retroviral protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3593214